v3.26.3
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 8,228 $ 21,259
Short-term investments 38,937 18,772
Prepaid expenses and other current assets 2,430 263
Restricted cash 135 80
Deferred offering costs 627 0
Total current assets 50,357 40,374
Investments 16,061 16,247
Deferred offering costs 0 533
Restricted cash 54 109
Operating lease right-of-use asset 1,479 1,764
Total assets 67,951 59,027
Current liabilities:    
Accounts payable 3,601 2,225
Accrued expenses 2,502 2,791
Deferred revenue 0 235
Operating lease liability, current portion 549 483
Total current liabilities 6,652 5,734
Warrant liability 980 2,225
Operating lease liability 1,272 1,692
Total liabilities 8,904 9,651
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value, authorized 5,000,000 shares as of September 30, 2026 and December 31, 2025; 0 shares issued and outstanding as of September 30, 2026 and December 31, 2025 0 0
Common stock, $0.001 par value, 60,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 9,952,738 and 5,442,688 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively 10 5
Additional paid-in capital 466,541 434,515
Accumulated deficit (407,504) (385,144)
Total stockholders' equity 59,047 49,376
Total liabilities and stockholders’ equity $ 67,951 $ 59,027